Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-003237

Chief Business Officer gave up 973 shares (to pay taxes)

  • Chief Business Officer acquired 3,320 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Luu Brendan Chief Business Officer 2024-02-12 Grant or award +3,320 40,056 D
Luu Brendan Chief Business Officer 2024-02-12 Shares withheld for taxes −973 $12.41 $12,075 39,083 D
Loading xslF345X05/form4.xml…